ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 307 out of 2588

$621K Total Retail Price of All Prescriptions

Rank: 309 out of 2588

413 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

20% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,293 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 562 497 1 2
HYDROCODONE-ACETAMINOPHEN 413 257 S3 2 7
OMEPRAZOLE 378 358 3 6
SIMVASTATIN 369 322 4 1
AMLODIPINE BESYLATE 340 318 5 4
FUROSEMIDE 313 260 6 5
POTASSIUM CHLORIDE 269 230 7 15
CARVEDILOL 233 204 8 20
LISINOPRIL 227 209 9 3
ZOLPIDEM TARTRATE 217 170 10 24
SERTRALINE HCL 209 202 11 26
METOPROLOL TARTRATE 202 195 12 9
METFORMIN HCL 188 140 13 8
PRAMIPEXOLE DIHYDROCHLORIDE 173 136 14 188
GLIMEPIRIDE 167 165 15 39
LOSARTAN-HYDROCHLOROTHIAZIDE 145 145 16 66
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 122 17 35
METOPROLOL SUCCINATE 126 114 18 12
GABAPENTIN 115 58 19 18
ALLOPURINOL 115 105 19 33
LOSARTAN POTASSIUM 115 91 19 17
ATENOLOL 113 111 22 14
ISOSORBIDE MONONITRATE ER 111 105 23 49
CIPROFLOXACIN HCL 102 83 24 82
TAMSULOSIN HCL 96 84 25 23
TRAMADOL HCL 95 81 26 19
HYDRALAZINE HCL 92 92 27 53
PLAVIX 90 78 28 43
WARFARIN SODIUM 89 75 29 10
TRIAMTERENE-HCTZ 88 71 30 46
DIGOXIN 88 78 30 38
CRESTOR 88 59 30 25
CLOPIDOGREL 87 77 33 30
MELOXICAM 85 72 34 51
LEVOFLOXACIN 79 68 35 77
AMLODIPINE BESYLATE-BENAZEPRIL 78 66 36 76
NEXIUM 77 58 37 41
JANUMET 77 77 37 211
PANTOPRAZOLE SODIUM 77 57 37 28
VYTORIN 73 62 40 200
ATORVASTATIN CALCIUM 73 73 40 11
BENAZEPRIL HCL 71 71 42 84
PRAVASTATIN SODIUM 71 69 42 16
MECLIZINE HCL 71 60 42 120
HYDROCHLOROTHIAZIDE 69 55 45 13
NAPROXEN 67 61 46 95
SPIRONOLACTONE 63 26 47 58
FLUTICASONE PROPIONATE 60 42 48 40
LANTUS SOLOSTAR 59 21 49 93
OXYBUTYNIN CHLORIDE ER 55 55 50 85
EXFORGE 55 55 50 209
PREDNISONE 54 50 52 42
CARBIDOPA-LEVODOPA 53 52 53 83
CITALOPRAM HBR 53 49 53 27
KLOR-CON M20 52 42 55 52
MIRTAZAPINE 52 40 55 63
DILTIAZEM 24HR CD 50 50 57 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.